SLTA Gold mining in Argentina
JUJUY, ARGENTINA--(Marketwired - Apr 2, 2013) - Dr. Fabio Montanari, President and CEO of Soltera Mining Corp. (SLTA) (www.solteramining.com), is pleased to announce that the 2012 field programs of bedrock sampling and geophysics on its El Torno property in Argentina produced very satisfactory results.
The 78 square kilometer El Torno property in the high Andes of northern Argentina contains a very large quartz vein system extending intermittently for 14 kilometers. Gold is found in narrow veins both within and outside this main system. The central parts have been worked since the Incas, resulting in about 1 km of underground galleries; and exploration programs in the late 1990s by mining companies, Penoles and Puma Minerals, concluded there is potential for 2 million ounces of gold to a depth of 400 meters (not NI 43-101 compliant.)
SLTA Gold mining in Argentina JUJUY,
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding Rollins' Current Market Position and Outlook
Analyzing Rollins Inc.'s Stock Performance As we look at the current performance of Rollins Inc. (NYSE: ROL), the shares are trading around $55.73, reflecting a decrease of 1.24% in the recent session. While the stock has dipped by 3.81% over the past month, it has impressively increased by 10.91% year-over-year. This presents a curious juxtaposition of short-term...
Continue Reading
Silver One Reports Major Mineral Resource Estimate for Candelaria
Candelaria Project Mineral Resource Estimate Silver One Resources Inc. (OTCQX: SLVRF) has made a significant announcement regarding the completion of a mineral resource estimate for the Candelaria Project. This estimate is prepared in accordance with the National Instrument 43-101, ensuring that the resources are assessed with high standards of transparency and accuracy....
Continue Reading
Investors Alert: Zynex (ZYXI) Faces Serious Legal Scrutiny
Legal Investigation into Zynex, Inc. The Law Offices of Frank R. Cruz have announced a crucial investigation regarding Zynex, Inc. (ZYXI) focused on potential violations of federal securities laws. This investigation comes as a response to significant concerns raised about the company's recent financial disclosures and their implications for investors. Understanding the...
Continue Reading
Understanding Rentokil Initial's Stock Valuation Insights
Assessing Rentokil Initial's Stock Performance In the current trading session, Rentokil Initial Inc. (NYSE: RTO) shares are priced at $26.42, witnessing a notable increase of 1.46%. Over the past month, the stock has gained 1.40%, though it has faced a decline of 7.78% in the last year. This fluctuation raises questions among shareholders regarding its valuation, despite...
Continue Reading
Innovative Insights on Efzofitimod from aTyr Pharma's Recent Conference
aTyr Pharma Highlights Efzofitimod at Key Conference At a significant scientific gathering, aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology firm known for its innovative therapeutic approaches, shared compelling data concerning efzofitimod. This presentation underlined important insights about the treatment of pulmonary sarcoidosis. The conference, which...
Continue Reading